Global Enteric Disease Testing and Therapeutic Market Growth (Status and Outlook) 2023-2029

Global Enteric Disease Testing and Therapeutic Market Growth (Status and Outlook) 2023-2029

Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.

LPI (LP Information)' newest research report, the “Enteric Disease Testing and Therapeutic Industry Forecast” looks at past sales and reviews total world Enteric Disease Testing and Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Enteric Disease Testing and Therapeutic sales for 2023 through 2029. With Enteric Disease Testing and Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enteric Disease Testing and Therapeutic industry.

This Insight Report provides a comprehensive analysis of the global Enteric Disease Testing and Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enteric Disease Testing and Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Enteric Disease Testing and Therapeutic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enteric Disease Testing and Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enteric Disease Testing and Therapeutic.

The global Enteric Disease Testing and Therapeutic market size is projected to grow from US$ 2948.8 million in 2022 to US$ 3266 million in 2029; it is expected to grow at a CAGR of 1.5% from 2023 to 2029.

According to World Health Organization (WHO), around 2.2 million people are killed annually due to food and water-borne diarrheal diseases. There is an impending global demand for better diagnostic and therapeutic options to prevent the deaths from enteric diseases.

This report presents a comprehensive overview, market shares, and growth opportunities of Enteric Disease Testing and Therapeutic market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Bacterial Disease
Viral Disease
Parasitic Disease

Segmentation by application
Hospital
Specialty Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
GlaxoSmithKline
Becton Dickinson
bioMérieux
Sanofi
Bayer Pharma
Bio-Rad
Quest Diagnostics
Trinity Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.